𝔖 Bobbio Scriptorium
✦   LIBER   ✦

559 POSTER The role of the ErbB3/PI3K/AKT pathway in determining breast cancer cell sensitivity against the irreversible dual EGFR/ErbB2 inhibitor EKB-569

✍ Scribed by W. Shabbir; C. Brünner-Kubarth; M. Grusch; W. Berger; B. Marian; R. Wagner; D. Lötsch; C.C. Zielinski; T.W. Grunt


Book ID
119599715
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
56 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.